Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting

Anna M Mandalakas1, H Lester Kirchner, Gerhard Walzl

  • 11 Section on Retrovirology and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Insights

Improved interferon-gamma release assays (IGRAs) show promise for detecting tuberculosis (TB) infection in young children, especially those with HIV. These tests may offer advantages over the tuberculin skin test for targeted preventive therapy.

Area of Science:

  • Pediatric infectious diseases
  • Global health
  • Diagnostic test evaluation

Background:

  • Children, particularly those who are young, malnourished, and HIV-infected, face a high risk of tuberculosis (TB) morbidity and mortality.
  • Accurate detection of TB infection in children is challenging due to limited pediatric data and diagnostic limitations.

Purpose of the Study:

  • To identify improved diagnostic tests for detecting pediatric TB infection.
  • To compare the performance of the tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) in children.

Main Methods:

  • A prospective, community-based study involved 1,343 children aged 6 months to 15 years in TB-HIV high-burden settings.
  • Assessed the tuberculin skin test (TST) and two IGRAs: QuantiFERON-TB Gold In-Tube (QFT-GIT) and T-SPOT.TB.
  • Analyzed associations between test results and child characteristics, including HIV status and nutritional status.

Main Results:

  • Contact tracing identified TB in 8% of child contacts within 3 months.
  • IGRAs showed higher positivity than TST in children without documented TB contact.
  • Nearly 8% of children exhibited discordance between IGRA and TST results.
  • IGRAs correlated better with TB contact than TST (P=0.0011).
  • Indeterminate QFT-GIT results were more frequent in HIV-infected children (4.7%) compared to uninfected children (1.9%).
  • T-SPOT.TB showed rare indeterminate results (0.2%) unaffected by HIV status.
  • Test correlation with TB contact decreased with worsening malnutrition in HIV-infected children.

Conclusions:

  • Interferon-gamma release assays may offer advantages over the tuberculin skin test for identifying TB infection in young children, especially those recently exposed and HIV-infected.
  • IGRAs can improve targeted, cost-effective delivery of preventive TB therapy in high-burden settings.
  • Development of affordable TB infection tests holds significant potential for global TB control efforts.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
754
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
937
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K